关于SEBMC  
SEBMC章程  
SEBMC活动  
执行理事会
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZHOU ZEQI, PH.D
Vice President of Tianjin International Joint Academy of Biotechnology and Medicine

He has 20 years of antibody technology experience for cancer diagnostics and therapeutics.  Prior work in industry and academic includes positions as Vice President and Chief Scientific Officer of Egenix working on the co-development of antibody technologies for cancer diagnostics and therapeutic; Principal Scientist at Wyeth where he worked on the vaccine development for pneumococcal and meningococcal diseases; Senior Scientist at Bayer where he developed immunoassays for cancer diagnosis; Research Fellow and Instructor at Harvard Medical School.  He obtained his PhD degree in molecular and cellular biology in Ohio University and had his post-doctoral training in Harvard Medical School. He has published over 40 papers in peer-reviewed journals, and given 36 abstracts and poster presentations in international conferences.  Also he has 5 patents issued and 4 diagnostics products developed with FDA approval for the diagnosis and treatment of cancers.